Compare ASRT & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASRT | NTIC |
|---|---|---|
| Founded | 1995 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 83.1M |
| IPO Year | 2004 | 1996 |
| Metric | ASRT | NTIC |
|---|---|---|
| Price | $13.95 | $8.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 45.0K | 3.7K |
| Earning Date | 03-16-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $118,713,000.00 | $84,234,474.00 |
| Revenue This Year | N/A | $11.40 |
| Revenue Next Year | $16.87 | $8.70 |
| P/E Ratio | ★ N/A | $280.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $6.77 |
| 52 Week High | $13.90 | $11.22 |
| Indicator | ASRT | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 72.14 | 48.79 |
| Support Level | $0.69 | $8.55 |
| Resistance Level | N/A | $9.48 |
| Average True Range (ATR) | 0.68 | 0.23 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 98.27 | 46.05 |
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.